However, in the tumor microenvironment of NSCLC, the high density of PD-L1+TAM in tumor tissue predicted better survival in NSCLC patients who were treated with PD-1/PD-L1 inhibitors (40, 41). The gene discussed is CD274; the disease is neoplasm.